Hair Loss Treatment

For many, hair loss occurs as a natural part of the ageing process. Although hair loss rarely needs to be medically treated, many seek hair loss medication for cosmetic and personal purposes. Dependent upon the severity, both non-prescription and prescription hair growth treatments - such as Propecia or the generic, better value option Finasteride and Regaine (Minoxidil) - are available to stimulate hair growth. There is also Avodart (dutasteride) which although unlicensed in the UK has been widely used for many years as a prescription only option to treat hair loss. We will only prescribe dutasteride if you have already tried finasteride (the licenced product) for hair loss first.

Oxford Online Pharmacy provides an online consultation with a GMC registered doctor to treat hair loss in men. First select your hair loss treatment and complete the online doctor's questionnaire. Your details will then be reviewed by our doctor. If you already have a private prescription, you can select the correct treatment and send your prescription to Oxford Online Pharmacy. Your hair growth products will be dispensed and sent discreetly to you as soon as we have received your prescription.

Important information about side-effects of these medications:

 Finasteride (Propecia) and Avodart (dutasteride) cause the lowering of your natural testosterone levels (rarely) leading to side effects such as impotence and prostate problems. In addition, a very small number of patients have reported symptoms of depression and (rarely) suicidal thoughts.

A recent study has concluded:

How Hair Loss Treatment Can Work For You

The loss of hair can have a detrimental impact on a person’s confidence, whether the hair loss is temporary or part of the natural ageing process. Hair loss may also be caused by alopecia areata when there is an imbalance in the body's immune system; stress, anaemia, fungal infections and chemotherapy can also result in baldness.

If you have started to experience hair loss, we understand that you may feel worried. However, there are a wide variety of both nonprescription and prescription hair loss treatments for men and women available. These treatments come in a variety of forms, from tablets to spray, foam and shampoo. All hair loss treatments work to stimulate the growth of new hairs, strengthen existing hairs and reduce thinning.

Prescription Hair Loss Treatment For Men

Male pattern baldness is largely genetic and affects around half of men. As the most common form of hair loss, male pattern baldness commonly begins with a receding hairline, followed by thinning at the temples and crown. This baldness, or alopecia, is caused by oversensitive hair follicles, resulting in the hair becoming thinner and growing for a shorter period of time. It is linked to the hormone Dihydrotestosterone, otherwise known as DHT, too much DHT and hairs fall out at a faster rate.

Male pattern baldness can be treated effectively with two prescription hair growth treatments:

Propecia (Finasteride) is a hair loss treatment for men and is available on private prescription from your online GP. Propecia comes in a tablet containing Finasteride that you take once every day. This treatment prevents testosterone converting into DHT, therefore increasing the growth of hair and postponing hair loss.

There is an alternative treatment called Avodart (dutasteride) for male hair loss. This is available through our service if the doctor considers it appropriate. Please contact us to discuss this option if needed.

To use the hair growth service you can take an online consultation with a GMC registered doctor If you are successful, you will be issued a private prescription. If you are unsuccessful, your money will be refunded. Alternatively, if you have a private or NHS prescription, you can order the treatment online and send your prescription to Oxford Online Pharmacy. When we have received your prescription, the prescribed medication will be dispensed and sent to your chosen address.

Authored by Stuart Gale, on 22 November 2016. Reviewed by Robert Bradshaw, on 08 September 2020